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hand-sewn conventional technique and at least one anastomosis
with the PAS-Port system. Patient follow-up consisted of multi-
slice computed tomographic scans or coronary angiogram per-
formed at discharge and 6 months postoperatively.
Results: Twenty-seven proximal anastomosis was performed
using PAS-Port and 15 anastomosis done using hand-sewn tech-
nique. In two patients severe atherosclerosis of the aorta required
to do all proximal anastomosis using the PAS-Port device. All the
Pas-Port anastomosis were done successfully. Time needed for
completion of the proximal anastomosis including graft loading
was 152 ± 19 s for the PAS-Port. No mortality or stroke seen
early or at fellow-up. Patency at discharge was 100% in both
PAS-Port and hand-sewn group and after 6 months.
Conclusions: This study demonstrated excellent short and mid-
term patency in both the hand-sewn and PAS-Port grafts. The
PAS-Port system allowed for the rapid, safe, and effective creation
of a proximal anastomosis without the need to clamp the aorta.
Based on this study we consider this product a valid alternative
for proximal anastomosis, especially in patients with severe aortic
disease, to avoid side clamping of the aorta.
doi:10.1016/j.jsha.2011.02.111
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Incidence of human transplanted skeletal myoblast (SkM) cell
death in ischemic myocardium was higher after cell therapy. We
proposed that human SkM treated by human stromal cell-derived
factor (SDF-1 protein or transfected by SDF-1, precondition them
against oxidative or anoxic injury. The puriﬁcation of human SkM
(80–90%) culture was assessed for desmin and CXCR4 expression.
Cells were transfected to overexpress SDF-1f or treated with
rSDF-1 (10–200 ng/ml, 1–4 h) were either exposed to anoxia or
treated with 100 lM H2O2 for different time periods (1–6 h anox-
ia) (1–3 h H2O2). Optimized conditions for transfection of SDF-1
gene into human SkM were achieved, using FuGeneTM6/phSDF-
1 (3:2 v/w, 4 h transfection) with 125 lM ZnCl2 (p< 0.001), up to
7 days post-transfection as compared with transfected SkM with-
out ZnCl2 and non-transfected control cells. Transfection efﬁ-
ciency was assessed by immunostaining, ELISA, Western blots
and PCR. LDH analysis showed signiﬁcant decrease in release
of LDH after exposure to 6 h anoxia or 100 lM H2O2 for 2 h as
compared with the normal un-treated or untransfected SkM
(p< 0.001). In Western-blots assay, SDF-1 over-expressing hu-
man SkM or treated with rSDF-1 induced marked expression of
total Akt (1.2-fold) and phospho-Akt (2.7-fold), Bcl2 (1.6-fold)
and VEGF (5.8-fold) after exposure to 6 h anoxia as compared
with human SkM controls. SDF-1 transgene delivery of human
SkM induced signal transduction that increased cell survival and
release of VEGF that promoted cytoprotective effect against oxi-
dative or anoxic injury. The preconditioning of donor trans-
planted human SkM with SDF-1 may be an innovative
approach for clinical application.
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Objective: Is to compare the inﬂuence of the internal thoracic
artery (ITA) harvesting technique on longterm outcome after OP-
CAB surgery.
Methods: 1250 consecutive patients underwent OPCAB be-
tween 1996 and 2006 at our institute. From September 1996 to
January 2000 patients ITAs were pedicled (PD) (n= 442), and
from February 2000 till May 2006 the ITAs were skeletonized
(SK) (n= 805). Three patients did not receive ITA graft. Overall
survival and occurrence of MACE were prospectively documented
for both groups. MACE were deﬁned as rehospitalization for
myocardial infarction, unstable angina, congestive heart failure,
new revascularization either percutaneous or surgical, and sudden
or cardiac death. Mean follow-up time was 66 ± 22 months and
was completed in 97% of the patients.
Results: SK-patients were older (p= 0.01), had a lower left
ventricular ejection (p= 0.009), and a higher prevalence of diabe-
tes, high blood pressure, obesity, pulmonary artery hypertension,
and recent MI. Number of distal anastomoses were higher in
SK-patients (p= 0.0001). A trend toward a lower prevalence of
wound infection in diabetic SK-patients with bilateral ITA har-
vesting (1.2% vs 4.6%) was observed. There were no differences
in operative and long-term overall mortality between both groups.
MACE-free survival at 1, 3 and 5 years were 96 ± 1%, 91 ± 1%,
86 ± 2% in SK-patients and 95 ± 1%, 91 ± 1.5%, 88 ± 2% in
PD patients (p= .87).
Conclusions: Even though SK patients were older and pre-
sented more preoperative comorbidities, they had a long-term out-
come comparable to PD-SK patients. Our results conﬁrm the
safety and efﬁciency of ITA skeletonization in OPCAB surgery.
doi:10.1016/j.jsha.2011.02.114
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